243 related articles for article (PubMed ID: 18094911)
1. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.
Allen MR; Gineyts E; Leeming DJ; Burr DB; Delmas PD
Osteoporos Int; 2008 Mar; 19(3):329-37. PubMed ID: 18094911
[TBL] [Abstract][Full Text] [Related]
2. Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
Allen MR; McNerny E; Aref M; Organ JM; Newman CL; McGowan B; Jang T; Burr DB; Brown DM; Hammond M; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Hutchins GD; Wallace JM
PLoS One; 2017; 12(8):e0181750. PubMed ID: 28793321
[TBL] [Abstract][Full Text] [Related]
3. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.
Tang SY; Allen MR; Phipps R; Burr DB; Vashishth D
Osteoporos Int; 2009 Jun; 20(6):887-94. PubMed ID: 18850239
[TBL] [Abstract][Full Text] [Related]
4. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
Allen MR; Iwata K; Phipps R; Burr DB
Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
[TBL] [Abstract][Full Text] [Related]
5. Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs.
Allen MR; Burr DB
Osteoporos Int; 2008 Jan; 19(1):95-9. PubMed ID: 17710353
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene enhances vertebral mechanical properties independent of bone density.
Allen MR; Iwata K; Sato M; Burr DB
Bone; 2006 Nov; 39(5):1130-1135. PubMed ID: 16814622
[TBL] [Abstract][Full Text] [Related]
7. Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone.
Allen MR; Erickson AM; Wang X; Burr DB; Martin RB; Hazelwood SJ
Calcif Tissue Int; 2010 Jan; 86(1):67-71. PubMed ID: 19953232
[TBL] [Abstract][Full Text] [Related]
8. Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra.
Diab T; Allen MR; Burr DB
Osteoporos Int; 2009 Apr; 20(4):647-52. PubMed ID: 18716822
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.
Gourion-Arsiquaud S; Allen MR; Burr DB; Vashishth D; Tang SY; Boskey AL
Bone; 2010 Mar; 46(3):666-72. PubMed ID: 19925895
[TBL] [Abstract][Full Text] [Related]
10. Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate.
Allen MR; Turek JJ; Phipps RJ; Burr DB
Bone; 2011 Jul; 49(1):128-32. PubMed ID: 20637914
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae.
Viguet-Carrin S; Roux JP; Arlot ME; Merabet Z; Leeming DJ; Byrjalsen I; Delmas PD; Bouxsein ML
Bone; 2006 Nov; 39(5):1073-1079. PubMed ID: 16829221
[TBL] [Abstract][Full Text] [Related]
12. Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs.
Burr DB; Miller L; Grynpas M; Li J; Boyde A; Mashiba T; Hirano T; Johnston CC
Bone; 2003 Dec; 33(6):960-9. PubMed ID: 14678856
[TBL] [Abstract][Full Text] [Related]
13. Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.
Saito M; Mori S; Mashiba T; Komatsubara S; Marumo K
Osteoporos Int; 2008 Sep; 19(9):1343-54. PubMed ID: 18373056
[TBL] [Abstract][Full Text] [Related]
14. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.
Allen MR; Burr DB
J Bone Miner Res; 2007 Nov; 22(11):1759-65. PubMed ID: 17663638
[TBL] [Abstract][Full Text] [Related]
15. Early effects of zoledronic acid and teriparatide on bone microarchitecture, remodeling and collagen crosslinks: comparison between iliac crest and lumbar vertebra in ewes.
Portero-Muzy NR; Chavassieux PM; Bouxsein ML; Gineyts E; Garnero P; Chapurlat RD
Bone; 2012 Oct; 51(4):714-9. PubMed ID: 22796591
[TBL] [Abstract][Full Text] [Related]
16. Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys.
Saito M; Marumo K; Kida Y; Ushiku C; Kato S; Takao-Kawabata R; Kuroda T
Osteoporos Int; 2011 Aug; 22(8):2373-83. PubMed ID: 20959962
[TBL] [Abstract][Full Text] [Related]
17. Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats.
Fuchs RK; Phipps RJ; Burr DB
J Bone Miner Res; 2008 Oct; 23(10):1689-97. PubMed ID: 18466070
[TBL] [Abstract][Full Text] [Related]
18. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.
Mashiba T; Turner CH; Hirano T; Forwood MR; Johnston CC; Burr DB
Bone; 2001 May; 28(5):524-31. PubMed ID: 11344052
[TBL] [Abstract][Full Text] [Related]
19. Effects of suppressed bone remodeling by minodronic acid and alendronate on bone mass, microdamage accumulation, collagen crosslinks and bone mechanical properties in the lumbar vertebra of ovariectomized cynomolgus monkeys.
Mashiba T; Saito M; Yamagami Y; Tanaka M; Iwata K; Yamamoto T
Bone; 2017 Apr; 97():184-191. PubMed ID: 28082077
[TBL] [Abstract][Full Text] [Related]
20. THE CLINICAL CHARACTERISTICS AND EFFICACY OF BISPHOSPHONATES IN AUDLT PATIENTS WITH OSTEOGENESIS IMPERGECTA.
Xu XJ; Ma DD; Lv F; Wang JY; Liu Y; Xia WB; Jiang Y; Wang O; Xing XP; Yu W; Li M
Endocr Pract; 2016 Nov; 22(11):1267-1276. PubMed ID: 27482615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
